Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

61.29

-1.53 (-2.44%)

At close: May 19, 2026, 4:00 PM EDT

61.36

+0.07 (0.11%)

After-hours: May 19, 2026, 6:22 PM EDT

Tarsus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,637	3,484	2,123	693	392	466
Market Cap Growth	32.52%	64.09%	206.51%	76.81%	-15.87%	-44.55%
Enterprise Value	2,337	3,139	1,904	495.15	194.23	293.91
Last Close Price	61.29	81.88	55.37	20.25	14.66	22.50
Forward PE	-	97.48	-	-	-	-
PS Ratio	4.93	7.72	11.61	39.71	15.18	8.17
PB Ratio	7.56	10.15	9.46	3.52	2.03	2.79
P/TBV Ratio	7.50	9.96	9.27	3.02	1.87	2.77
P/FCF Ratio	-	-	-	-	-	147.29
P/OCF Ratio	-	-	-	-	-	124.26
EV/Sales Ratio	4.37	6.96	10.41	28.38	7.52	5.15
EV/FCF Ratio	-	-	-	-	-	92.95
Debt / Equity Ratio	0.21	0.21	0.32	0.15	0.10	0
Net Debt / Equity Ratio	-0.91	-1.00	-0.98	-1.00	-1.02	-1.03
Net Debt / EBITDA Ratio	6.45	4.99	1.84	1.39	3.17	14.51
Net Debt / FCF Ratio	10.02	15.46	2.60	1.66	3.99	-54.34
Asset Turnover	0.94	0.96	0.57	0.07	0.13	0.33
Inventory Turnover	7.80	8.78	4.48	1.03	-	-
Quick Ratio	3.53	3.72	4.21	6.64	14.30	14.98
Current Ratio	3.74	3.85	4.42	6.93	14.61	15.33
Return on Equity (ROE)	-13.94%	-23.39%	-54.83%	-69.71%	-34.53%	-8.31%
Return on Assets (ROA)	-7.99%	-14.63%	-37.53%	-58.03%	-30.84%	-6.89%
Return on Invested Capital (ROIC)	-108.30%	-287.44%	-1099.13%	8229.84%	1397.11%	407.88%
Return on Capital Employed (ROCE)	-11.76%	-19.64%	-45.94%	-64.93%	-33.02%	-7.28%
FCF Yield	-	-	-	-	-	0.68%
Buyback Yield / Dilution	-10.54%	-11.11%	-27.98%	-19.35%	-19.78%	-231.12%
Total Shareholder Return	-10.54%	-11.11%	-27.98%	-19.35%	-19.78%	-231.12%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q